Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
Condition:   HPV 16+ Recurrent or Metastatic Cancer Interventions:   Biological: CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16;   Biological: Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16 Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   PapiVax Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2021 Category: Research Source Type: clinical trials

Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
Conditions:   Strongyloidiasis;   Bone Marrow Transplant Infection Intervention:   Other: None - standard of care Sponsor:   Imperial College Healthcare NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2021 Category: Research Source Type: clinical trials